ADC Therapeutics SA filed a Form S-3 registration statement with the SEC on November 9, 2026, to register 61,000,000 common shares for resale by selling shareholders who acquired the securities through securities purchase agreements dated October 7, 2026.
Trilogy Metals Inc. filed a Form S-3 registration statement with the SEC on November 10, 2026, covering the resale of up to 28,754,496 common shares held by or issuable to a Selling Shareholder.
Gregory S. Meyer filed a definitive proxy statement on November 10, 2026, soliciting shareholder support for his election to the Board of Directors of Vail Resorts, Inc. at the company's 2026 Annual Meeting scheduled for December 14, 2026.
CKX Lands, Inc. filed a Form 8-K on November 10, 2026, disclosing that on November 8, 2026, the company entered into an Investment Agreement with Jacobs Private Equity II, LLC and other investors providing for an aggregate cash investment of $1,000,000,000 in the company.
Braze, Inc. filed soliciting material under Schedule 14A on November 10, 2026, publishing a set of seven customer-facing frequently asked questions addressing the company's pending acquisition by Salesforce, Inc.
Lantheus Holdings, Inc. filed an 8-K on November 10, 2026, disclosing that on November 8, 2026, it entered into a definitive agreement to sell its contract development and manufacturing organization business and its Springfield, New Jersey manufacturing facility to PharmaLogic Holdings Corp.
CKX Lands, Inc. filed a current report on November 10, 2026, disclosing that on November 8, 2026, it entered into an Investment Agreement with Jacobs Private Equity II, LLC and other investors for an aggregate cash investment of $1,000,000,000 in the company.
WillScot Holdings Corporation filed a Form 8-K on November 9, 2026, disclosing that its subsidiary Williams Scotsman, Inc. entered into two forward-starting interest rate swap agreements on November 6, 2026, covering an aggregate notional amount of $300 million in variable-rate debt under its ABL …
Synchrony Financial filed a Form 8-K with the U.S. Securities and Exchange Commission on November 10, 2026, furnishing monthly charge-off and delinquency statistics covering the thirteen months ended October 31, 2026.
MetLife, Inc. filed a current report on November 10, 2026, disclosing that on November 9, 2026, it amended and restated its credit agreement, establishing a facility of up to $4,000,000,000 with an accordion option to $5,500,000,000.